HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva 29-31 March 2004 Summary.

Slides:

Advertisements

Similar presentations

Moving the process forward Sálvano Briceño UN/ISDR.

Advertisements

Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.

Harmonization of donor reporting requirements for antiretrovirals and related drugs Presented at the WHO meeting, Geneva ( October 2005) Oteba Olowo.

An operational package for Integrated Management of HIV/AIDS prevention, treatment and care ICASA - Abuja, Nigeria 5 December 2005.

Priority Issues and Strategic Information Needs for Kenya in scaling up ART.

Part A: Module A5 Session 2

CLICK TO ADD TITLE [DATE][SPEAKERS NAMES] The 5th Global Health Supply Chain Summit November , 2012 Kigali, Rwanda Supply Chain Performance Approaches.

Planning for Shifting HR Needs Malik Jaffer June 19, 2012.

Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.

Role of the laboratory in disease surveillance

Overview of “ITU-T SG5 Activities on Climate Change Adaptation” ” Nevine Tewfik Egypt Rapporteur of Question 15, ITU-T Study Group 5 Kuwait City, Kuwait,

HIV/AIDS mainstreaming in the workplace: an experience of CSO’s Tanzania AIDS Forum HIV/AIDS Technical review meeting Blue Peal Hotel, Dar Es Salaam 30.

HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva March 2004 Defining the variables.

Quantification in Resource- limited settings Laila Akhlaghi February 28, 2007.

Monitoring Drug and Commodity Supply Chains for ARV Programmes Yasmin Chandani John Snow Inc/DELIVER.

Contraception: The Best Kept Secret in HIV Prevention Global Health Mini-University October 27, 2006 Rose Wilcher & Heidi Reynolds.

Overview Burkina--- ART Population: 11 millions Prevalence: 6.6% (surveillance data) Estimate of 650,000 PLWHA 300 peoples with red cross 2000 people to.

Group Discussion Guyana, The Bahamas T & T, Jamaica Barbados, Haiti Suriname, Curacao.

2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.

Clinical Research Networks Notifications Practice Policy Stewardship Lives Saved Diagnostics Pathogenesis Incidence Outcome Risk Factors Treatment Public.

Global Trends in HIV/AIDS Monitoring and Evaluation Deborah Rugg, PhD Associate Director for Monitoring and Evaluation HHS/US Centers for Disease Control.

Challenges in monitoring ARV therapy A clinical and public health view of the issues involved Charlie Gilks SRM team, HIV department.

Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July

More than just reinventing the wheel … Evidence review: Linking SRH and HIV Alejandra Trossero Senior HIV Officer: Linking SRH and HIV.

Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.

Downloaded from Current Status of ART Opportunities & Challenges Kibrebeal Melaku,MD Associate Professor.

Justin Weligamage Department of Transport and Main Roads Queensland, Australia Collaboration and Partnership in Managing Skid Resistance for TMR Queensland.

The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.

The revised TB/HIV indicators and update on the process of harmonization Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group.

IAS Policy and Advocacy priority on Treatment as Prevention Carlos F. Cáceres Multidisciplinary Research on ARV-based Prevention 30 June 2013 Kuala Lumpur.

Lessons from Programme Evaluation in Romania First Annual Conference on Evaluation Bucharest 18 February 2008.

XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.

Overview of “ITU-T SG5 Activities on Climate Change Adaptation” ” Nevine Tewfik Egypt Rapporteur of Question 15, ITU-T Study Group 5 ITU Symposium on ICTs,

1 The United Nations Demographic Yearbook and the Work Programme for Social Statistics Expert Group Meeting to Review the United Nations Demographic Yearbook.

HIV/AIDS Track Session. Key Points Application of international reference price list during a national tender is a valuable tool for achieving optimal.

Group 1 Presentation: HIV Testing in TB Patients and ART Provision.

Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.

Harmonization of Information for Multilateral Environmental Agreements Inter-Linkages Conference, Tokyo July 1999 Mark Collins Chief Executive World.

Supply Chain Management. Nigeria: FBOs/NACA PEPFAR support for SCMI through EXIOS /FHI The CHAN formed a partnership with above to ensure adequate commodities.

Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.

MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,

Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.

New WHO Guidelines on Person centred monitoring

The Assistive Technology Information Mapping project

National and Global Monitoring of HIV Exposed, Uninfected Children

Development of the detailed Nutrition Response Plan

The need to promote a rights-based approach to Treatment

National audit of paediatric IBD service provision

POVERTY REDUCTION STRATEGY DEVELOPMENT PROCESS, MPLEMENTATION AND REVIEW TANZANIA EXPERIENCE SUSTAINING PARTICIPATION IN POVERTY REDUCTION STRATEGIES.

Agriculture Sector Wide Approach (ASWAp)

Capacity Building Enhance the coordination of efforts to strengthen individual, institutional and infrastructure capacities, particularly in developing.

HIV PREVENTION TARGETS FOR ZIMBABWE

8-9 August 2009, Bali, Indonesia

Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.

The importance of administrative data in the era of SDGs

OperationOC Operational Area Orange County Rescue Mission’s

CRUE – The Way Forward Vicki Jackson

D1 BIODIVERSITY REVIEW PROCESS

Steen Lau Jørgensen Director, Social Development World Bank

Forecasting – HIV/AIDS commodities Key challenges and lessons learned

Why are We Here? CHCF has a commitment to improve chronic disease care in California Creating financial incentives and addressing regulatory barriers.

Survive and bounce back

Paul De Lay Director, Evaluation UNAIDS

monitoring & evaluation THD Unit, Stop TB department WHO Geneva

The STOP TB Strategy – 2009 VISION: A TB-free world

Surveillance, Monitoring and Evaluation Working Group

Evaluating Community Link Working in Scotland: Learning from the ‘early adopters’ Jane Ford, NHS Health Scotland Themina Mohammed & Gordon Hunt, NSS Local.

Multisectoral Response

CEOS Analysis Ready Data Strategy

Presentation transcript:

HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva 29-31 March 2004 Summary

Objectives of the meeting (1) Harmonize collection of three data sets Basic info at patient level Linkages with other systems Mechanisms for collection Reporting and feedback at various levels Data systems

Cross Cutting Issues Diverse participants--? Improved linkages Settings (infrastructure, volume, etc) Chronicity Data needs Data collection Timeliness Quality improvement Confidentiality/Security Data use/Data feedback

What have we achieved? Refinement of Patient care/treatment card Refinement of program monitoring information Better understanding of data capturing systems Explored linkages/cross cutting issues Identified next questions and steps forward

Recommendations Further refinement of patient data card and program monitoring information/registeries Linking treatment card with registries WHO recommendations on confidentiality Early warning to detect supply stock outs to rapidly respond How to “de-identify” data sets Selection of data capturing systems (short and long term) Dissemination of recommendations Feedback-two way

The Big Questions How will we learn from this? How will we coordinate? Data uses and rationing? What about long term goals? Sustainability indicators Financing sources Cost for treatment and commodities Staffing patterns Sector wide impact Capacity to scale up Impact indicators Long term survival Quality of life/productivity ARV resistance Incident infections